# EDGAR Filing Document

**Accession Number:** 0001761055
**File Stem:** 0001410368-26-031697
**Filing Date:** 2026-3
**Character Count:** 54591
**Document Hash:** f8fa084b06cba9220fe5202cc414e29e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-26-031697.hdr.sgml**: 20260326

**ACCESSION NUMBER**: 0001410368-26-031697

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260131

**FILED AS OF DATE**: 20260326

**DATE AS OF CHANGE**: 20260326

**PERIOD START**: 20260731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BlackRock ETF Trust
- **CENTRAL INDEX KEY:** 0001761055

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23402
- **FILM NUMBER:** 26795862

**BUSINESS ADDRESS:**
- **STREET 1:** 100 BELLEVUE PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809
- **BUSINESS PHONE:** 8004417762

**MAIL ADDRESS:**
- **STREET 1:** 100 BELLEVUE PARKWAY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19809

## Series and Classes Contracts Data

### iShares Health Innovation Active ETF (Series ID: S000069260)

| Class ID   | Class Name                           | Ticker Symbol   |
|:---|:---|:---|
| C000221226 | iShares Health Innovation Active ETF |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** BlackRock ETF Trust

- **b. Investment Company Act file number:** 811-23402

- **c. CIK number of Registrant:** 0001761055

- **d. LEI of Registrant:** 5493007WBHAKV9JVS642

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 100 BELLEVUE PARKWAY

  - **City:** WILMINGTON

  - **State:** DE

  - **Foreign country:** US

  - **Zip / Postal Code:** 19809

  - **Telephone number:** 800-441-7762

**Item A.2. Information about the Series.**

- **a. Name of Series:** iShares Health Innovation Active ETF

- **b. EDGAR series identifier (if any):** S000069260

- **c. LEI of Series:** 549300QSHQQEGUGOU050

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-07-31

- **b. Date as of which information is reported:** 2026-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $10757429.31

**Total Liabilities:** $818617.25

**Net Assets:** $9938812.06

**Cash Not Reported:** $208.23

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000221226 | 8.57%                | -2.11%               | 2.55%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $46290.99                | $442251.09                                 |
| Month 2  | $49258.07                | $-206848.55                                |
| Month 3  | $-25590.93               | $170495.34                                 |

**Designated Index Information**

- **Index Name:** STOXX GLOBAL BREAKTHROUGH HEALTHCARE

- **Index Identifier:** STFSHIUN

### Schedule of Portfolio Investments

| Name                                           | Title                                                 | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Abbott Laboratories                            | Abbott Laboratories                                   | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |       632 | NS      | $69077.60     | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                                     | AbbVie Inc                                            | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |       643 | NS      | $143395.43    | 1.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Abivax SA                                      | Abivax SA                                             | CUSIP: 00370M103<br>LEI: 969500D8TMNB184OJU95 | Long             | EC               | CORP              | FR        |        80 | NS      | $8892.00      | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA ABIOMED INC                             | CONTRA ABIOMED INC                                    | CUSIP: 003CVR016<br>LEI: N/A                  | Long             |  | CORP              | US        |       246 | NS      | $570.72       | 0.01%             |  |  |  | No            |                  3 | On Loan: No      |
| Agilent Technologies Inc                       | Agilent Technologies Inc                              | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |      1345 | NS      | $180028.25    | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Agios Pharmaceuticals Inc                      | Agios Pharmaceuticals Inc                             | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |       892 | NS      | $24476.48     | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Aktis Oncology Inc                             | Aktis Oncology Inc                                    | CUSIP: 01021M104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       531 | NS      | $10752.75     | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics Inc                      | Allogene Therapeutics Inc                             | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3144 | NS      | $5784.96      | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Alumis Inc                                     | Alumis Inc                                            | CUSIP: 022307102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       923 | NS      | $22622.73     | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                                    | Cencora Inc                                           | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |       137 | NS      | $49213.14     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                      | Amgen Inc                                             | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |       488 | NS      | $166837.44    | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc                        | Apogee Therapeutics Inc                               | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       368 | NS      | $24107.68     | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx Inc                                    | Arcellx Inc                                           | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       561 | NS      | $38321.91     | 0.39%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcus Biosciences Inc                          | Arcus Biosciences Inc                                 | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1808 | NS      | $38040.32     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                      | Argenx SE                                             | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |       160 | NS      | $134480.00    | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                                    | Arvinas Inc                                           | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1040 | NS      | $13915.20     | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S                            | Ascendis Pharma A/S                                   | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |        43 | NS      | $9722.30      | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| AstraZeneca PLC                                | AstraZeneca PLC                                       | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |      1056 | NS      | $97965.12     | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Autolus Therapeutics PLC                       | Autolus Therapeutics PLC                              | CUSIP: 05280R100<br>LEI: 549300C0KZP8EYROLL02 | Long             | EC               | CORP              | GB        |      3256 | NS      | $4460.72      | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Avalo Therapeutics Inc                         | Avalo Therapeutics Inc                                | CUSIP: 05338F306<br>LEI: 549300GPK6FPJ3X8SZ39 | Long             | EC               | CORP              | US        |       272 | NS      | $4109.92      | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Avidity Biosciences Inc                        | Avidity Biosciences Inc                               | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       138 | NS      | $10014.66     | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc                        | Axsome Therapeutics Inc                               | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |       261 | NS      | $48089.25     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc                          | Beam Therapeutics Inc                                 | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       810 | NS      | $22372.20     | 0.23%             |  |  |  | No            |                  1 | On Loan: —       |
| BeOne Medicines Ltd                            | BeOne Medicines Ltd                                   | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | CH        |       161 | NS      | $54801.18     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicycle Therapeutics PLC                       | Bicycle Therapeutics PLC                              | CUSIP: 088786108<br>LEI: 213800XKUI6R7GKC3E43 | Long             | EC               | CORP              | GB        |       392 | NS      | $2516.64      | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Rad Laboratories Inc                       | Bio-Rad Laboratories Inc                              | CUSIP: 090572207<br>LEI: 549300ZC1GPV35XYDK53 | Long             | EC               | CORP              | US        |       162 | NS      | $47579.40     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc                    | BioMarin Pharmaceutical Inc                           | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |       338 | NS      | $19110.52     | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                     | Biogen Inc                                            | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |      1163 | NS      | $209212.07    | 2.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Techne Corp                                | Bio-Techne Corp                                       | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |      1826 | NS      | $117028.34    | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                                    | BioNTech SE                                           | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |       122 | NS      | $13877.50     | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA BLUEPRINT MEDIC                         | CONTRA BLUEPRINT MEDIC                                | CUSIP: 096CVR048<br>LEI: 5299004CC60O9T5HVM83 | Long             |  | CORP              | US        |       110 | NS      | $107.80       | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Boston Scientific Corp                         | Boston Scientific Corp                                | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |      1130 | NS      | $105688.90    | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc                           | Bridgebio Pharma Inc                                  | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |      1472 | NS      | $113741.44    | 1.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Bright Minds Biosciences Inc                   | Bright Minds Biosciences Inc                          | CUSIP: 10919W405<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |       339 | NS      | $26357.25     | 0.27%             |  |  |  | No            |                  1 | On Loan: —       |
| Bristol-Myers Squibb Co                        | Bristol-Myers Squibb Co                               | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |      1620 | NS      | $89181.00     | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Bruker Corp                                    | Bruker Corp                                           | CUSIP: 116794108<br>LEI: LEBZ6VLQ6I8XB1NHVY15 | Long             | EC               | CORP              | US        |       698 | NS      | $30914.42     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Charles River Laboratories International Inc   | Charles River Laboratories International Inc          | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |       658 | NS      | $138495.84    | 1.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc                         | Cogent Biosciences Inc                                | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1273 | NS      | $45713.43     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Corvus Pharmaceuticals Inc                     | Corvus Pharmaceuticals Inc                            | CUSIP: 221015100<br>LEI: 549300I3AVJ8F75NCX65 | Long             | EC               | CORP              | US        |       225 | NS      | $4657.50      | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics Inc                               | Cytokinetics Inc                                      | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |       360 | NS      | $22748.40     | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                                   | Danaher Corp                                          | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |       714 | NS      | $156287.46    | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Denali Therapeutics Inc                        | Denali Therapeutics Inc                               | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |      1729 | NS      | $37588.46     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Dexcom Inc                                     | Dexcom Inc                                            | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |      1875 | NS      | $136950.00    | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Dianthus Therapeutics Inc                      | Dianthus Therapeutics Inc                             | CUSIP: 252828108<br>LEI: 549300Z3N6ODPCOFC890 | Long             | EC               | CORP              | US        |       167 | NS      | $8916.13      | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Disc Medicine Inc                              | Disc Medicine Inc                                     | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       209 | NS      | $16159.88     | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Dyne Therapeutics Inc                          | Dyne Therapeutics Inc                                 | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       880 | NS      | $15743.20     | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc                      | Edgewise Therapeutics Inc                             | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       937 | NS      | $26376.55     | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp                      | Edwards Lifesciences Corp                             | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |      3008 | NS      | $244730.88    | 2.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Elanco Animal Health Inc                       | Elanco Animal Health Inc                              | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |      2280 | NS      | $54902.40     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Enanta Pharmaceuticals Inc                     | Enanta Pharmaceuticals Inc                            | CUSIP: 29251M106<br>LEI: 529900SSN4DODDQSN594 | Long             | EC               | CORP              | US        |       712 | NS      | $9184.80      | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc                       | Enliven Therapeutics Inc                              | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       492 | NS      | $13013.40     | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Erasca Inc                                     | Erasca Inc                                            | CUSIP: 29479A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1460 | NS      | $15344.60     | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp                            | Exact Sciences Corp                                   | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |      2857 | NS      | $292385.38    | 2.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis Inc                                   | Exelixis Inc                                          | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |      2281 | NS      | $94342.16     | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| EyePoint Inc                                   | EyePoint Inc                                          | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |       760 | NS      | $10275.20     | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| 4D Molecular Therapeutics Inc                  | 4D Molecular Therapeutics Inc                         | CUSIP: 35104E100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       472 | NS      | $4181.92      | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA FREQUENCY THERA                         | CONTRA FREQUENCY THERA                                | CUSIP: 358CVR025<br>LEI: N/A                  | Long             |  | CORP              | US        |       420 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Gilead Sciences Inc                            | Gilead Sciences Inc                                   | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      2155 | NS      | $305902.25    | 3.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Gossamer Bio Inc                               | Gossamer Bio Inc                                      | CUSIP: 38341P102<br>LEI: 549300ZOC0N2W6PSFR58 | Long             | EC               | CORP              | US        |       546 | NS      | $1244.88      | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                            | Guardant Health Inc                                   | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |      2392 | NS      | $272783.68    | 2.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc                      | Halozyme Therapeutics Inc                             | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |       680 | NS      | $48762.80     | 0.49%             |  |  |  | No            |                  1 | On Loan: —       |
| Harmony Biosciences Holdings Inc               | Harmony Biosciences Holdings Inc                      | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       578 | NS      | $21108.56     | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Hologic Inc                                    | Hologic Inc                                           | CUSIP: 436440101<br>LEI: 549300DYP6F5ZJL0LB74 | Long             | EC               | CORP              | US        |      1474 | NS      | $110446.82    | 1.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                   | Illumina Inc                                          | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |      1258 | NS      | $182170.98    | 1.83%             |  |  |  | No            |                  1 | On Loan: —       |
| Immunome Inc                                   | Immunome Inc                                          | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       640 | NS      | $15756.80     | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunocore Holdings PLC                        | Immunocore Holdings PLC                               | CUSIP: 45258D105<br>LEI: 213800IUE3DFS84BVN18 | Long             | EC               | CORP              | GB        |       586 | NS      | $19074.30     | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                    | Incyte Corp                                           | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |       434 | NS      | $43430.38     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Insulet Corp                                   | Insulet Corp                                          | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |       415 | NS      | $106161.15    | 1.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc                      | Intellia Therapeutics Inc                             | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |      1200 | NS      | $15780.00     | 0.16%             |  |  |  | No            |                  1 | On Loan: —       |
| Genmab A/S                                     | Genmab A/S                                            | CUSIP: 000000000<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |       605 | NS      | $197100.21    | 1.98%             |  |  |  | No            |                  2 | On Loan: No      |
| Intuitive Surgical Inc                         | Intuitive Surgical Inc                                | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |       258 | NS      | $130088.76    | 1.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals Inc                      | Ionis Pharmaceuticals Inc                             | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |      1610 | NS      | $133098.70    | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc                             | IQVIA Holdings Inc                                    | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |       960 | NS      | $220944.00    | 2.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                              | Johnson & Johnson                                     | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |      1561 | NS      | $354737.25    | 3.57%             |  |  |  | No            |                  1 | On Loan: No      |
| KalVista Pharmaceuticals Inc                   | KalVista Pharmaceuticals Inc                          | CUSIP: 483497103<br>LEI: 529900Q7IDA3WUGRZA51 | Long             | EC               | CORP              | US        |       633 | NS      | $9881.13      | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Kodiak Sciences Inc                            | Kodiak Sciences Inc                                   | CUSIP: 50015M109<br>LEI: 254900IXI5NI8C9OQE24 | Long             | EC               | CORP              | US        |       322 | NS      | $7331.94      | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| LB Pharmaceuticals Inc                         | LB Pharmaceuticals Inc                                | CUSIP: 50180M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1779 | NS      | $38159.55     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Lantheus Holdings Inc                          | Lantheus Holdings Inc                                 | CUSIP: 516544103<br>LEI: 5299005HUB5IOJGO7S39 | Long             | EC               | CORP              | US        |       489 | NS      | $32723.88     | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| MBX Biosciences Inc                            | MBX Biosciences Inc                                   | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1392 | NS      | $51295.20     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                                         | UCB SA                                                | CUSIP: 000000000<br>LEI: 2138008J191VLSGY5A09 | Long             | EC               | CORP              | BE        |       404 | NS      | $123109.08    | 1.24%             |  |  |  | No            |                  2 | On Loan: No      |
| Maze Therapeutics Inc                          | Maze Therapeutics Inc                                 | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       397 | NS      | $17301.26     | 0.17%             |  |  |  | No            |                  1 | On Loan: —       |
| McKesson Corp                                  | McKesson Corp                                         | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |        58 | NS      | $48210.18     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Sartorius AG                                   | Sartorius AG                                          | CUSIP: 000000000<br>LEI: 529900EQV2DY4FOAMU38 | Long             | EP               | CORP              | DE        |       514 | NS      | $143659.33    | 1.45%             |  |  |  | No            |                  2 | On Loan: No      |
| Medline Inc                                    | Medline Inc                                           | CUSIP: 58507V107<br>LEI: 984500FAN6J1P8566D43 | Long             | EC               | CORP              | US        |      1274 | NS      | $56310.80     | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                                 | Merck & Co Inc                                        | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |      2402 | NS      | $264868.54    | 2.66%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA MIRATI THERAPEU                         | CONTRA MIRATI THERAPEU                                | CUSIP: 604CVR027<br>LEI: 529900GYRW59IDQV6N54 | Long             |  | CORP              | US        |       334 | NS      | $263.86       | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Moderna Inc                                    | Moderna Inc                                           | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |      4989 | NS      | $219865.23    | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Monte Rosa Therapeutics Inc                    | Monte Rosa Therapeutics Inc                           | CUSIP: 61225M102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       642 | NS      | $13173.84     | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Eisai Co Ltd                                   | Eisai Co Ltd                                          | CUSIP: 000000000<br>LEI: 353800HDEE0ZYEX4QV91 | Long             | EC               | CORP              | JP        |      3300 | NS      | $92002.13     | 0.93%             |  |  |  | No            |                  2 | On Loan: No      |
| Natera Inc                                     | Natera Inc                                            | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |       896 | NS      | $207101.44    | 2.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                     | Neurocrine Biosciences Inc                            | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |       865 | NS      | $117691.90    | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                                   | Nuvalent Inc                                          | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       561 | NS      | $57721.29     | 0.58%             |  |  |  | No            |                  1 | On Loan: —       |
| Nuvation Bio Inc                               | Nuvation Bio Inc                                      | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3067 | NS      | $16071.08     | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Ocular Therapeutix Inc                         | Ocular Therapeutix Inc                                | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |       776 | NS      | $7092.64      | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Olema Pharmaceuticals Inc                      | Olema Pharmaceuticals Inc                             | CUSIP: 68062P106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       921 | NS      | $23688.12     | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| ORIC Pharmaceuticals Inc                       | ORIC Pharmaceuticals Inc                              | CUSIP: 68622P109<br>LEI: 54930033FJRNEYBW0L25 | Long             | EC               | CORP              | US        |      1042 | NS      | $10690.92     | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Oruka Therapeutics Inc                         | Oruka Therapeutics Inc                                | CUSIP: 687604108<br>LEI: 529900TG7O4ESUDMGI54 | Long             | EC               | CORP              | US        |       504 | NS      | $17251.92     | 0.17%             |  |  |  | No            |                  1 | On Loan: —       |
| PTC Therapeutics Inc                           | PTC Therapeutics Inc                                  | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |       308 | NS      | $23263.24     | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Penumbra Inc                                   | Penumbra Inc                                          | CUSIP: 70975L107<br>LEI: 549300RGE06P3ECANU72 | Long             | EC               | CORP              | US        |       208 | NS      | $74499.36     | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                                    | Novartis AG                                           | CUSIP: 000000000<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |      1419 | NS      | $210536.71    | 2.12%             |  |  |  | No            |                  2 | On Loan: No      |
| Roche Holding AG                               | Roche Holding AG                                      | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |       574 | NS      | $261020.50    | 2.63%             |  |  |  | No            |                  2 | On Loan: No      |
| Pfizer Inc                                     | Pfizer Inc                                            | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |      1794 | NS      | $47433.36     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| EssilorLuxottica SA                            | EssilorLuxottica SA                                   | CUSIP: 000000000<br>LEI: 549300M3VH1A3ER1TB49 | Long             | EC               | CORP              | FR        |       136 | NS      | $41574.63     | 0.42%             |  |  |  | No            |                  2 | On Loan: No      |
| Lonza Group AG                                 | Lonza Group AG                                        | CUSIP: 000000000<br>LEI: 549300EFW4H2TCZ71055 | Long             | EC               | CORP              | CH        |       212 | NS      | $144043.41    | 1.45%             |  |  |  | No            |                  2 | On Loan: No      |
| Protagonist Therapeutics Inc                   | Protagonist Therapeutics Inc                          | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       745 | NS      | $60941.00     | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| RadNet Inc                                     | RadNet Inc                                            | CUSIP: 750491102<br>LEI: 529900RECG94V2IZJ970 | Long             | EC               | CORP              | US        |       433 | NS      | $30353.30     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENXBIO Inc                                  | REGENXBIO Inc                                         | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               | CORP              | US        |       816 | NS      | $9106.56      | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Repligen Corp                                  | Repligen Corp                                         | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |      1040 | NS      | $155344.80    | 1.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc                       | Revolution Medicines Inc                              | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |       506 | NS      | $49056.70     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Rezolute Inc                                   | Rezolute Inc                                          | CUSIP: 76200L309<br>LEI: 549300T05L48T72P2G08 | Long             | EC               | CORP              | US        |       972 | NS      | $3246.48      | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc                     | Rhythm Pharmaceuticals Inc                            | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |      1209 | NS      | $123946.68    | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp                      | Scholar Rock Holding Corp                             | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |       336 | NS      | $14898.24     | 0.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Stoke Therapeutics Inc                         | Stoke Therapeutics Inc                                | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |      1416 | NS      | $42961.44     | 0.43%             |  |  |  | No            |                  1 | On Loan: —       |
| Summit Therapeutics Inc                        | Summit Therapeutics Inc                               | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1041 | NS      | $15073.68     | 0.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Tempus AI Inc                                  | Tempus AI Inc                                         | CUSIP: 88023B103<br>LEI: 2549009LA0KWRAGQBX50 | Long             | EC               | CORP              | US        |       840 | NS      | $50248.80     | 0.51%             |  |  |  | No            |                  1 | On Loan: —       |
| Terns Pharmaceuticals Inc                      | Terns Pharmaceuticals Inc                             | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |      1425 | NS      | $49305.00     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Teva Pharmaceutical Industries Ltd             | Teva Pharmaceutical Industries Ltd                    | CUSIP: 881624209<br>LEI: 549300BAFGM4RC74ZJ94 | Long             | EC               | CORP              | IL        |      2298 | NS      | $78315.84     | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc                   | Thermo Fisher Scientific Inc                          | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |       251 | NS      | $145231.11    | 1.46%             |  |  |  | No            |                  1 | On Loan: No      |
| TScan Therapeutics Inc                         | TScan Therapeutics Inc                                | CUSIP: 89854M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4466 | NS      | $4555.32      | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Upstream Bio Inc                               | Upstream Bio Inc                                      | CUSIP: 91678A107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       507 | NS      | $15757.56     | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Ventyx Biosciences Inc                         | Ventyx Biosciences Inc                                | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2312 | NS      | $32252.40     | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                     | Vertex Pharmaceuticals Inc                            | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |        73 | NS      | $34302.70     | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc                        | Viking Therapeutics Inc                               | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |       757 | NS      | $21983.28     | 0.22%             |  |  |  | No            |                  1 | On Loan: —       |
| CONTRA VIGIL NEUROSCIE                         | CONTRA VIGIL NEUROSCIE                                | CUSIP: 926CVR010<br>LEI: N/A                  | Long             |  | CORP              | US        |       484 | NS      | $24.20        | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Vir Biotechnology Inc                          | Vir Biotechnology Inc                                 | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       905 | NS      | $6733.20      | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Viridian Therapeutics Inc                      | Viridian Therapeutics Inc                             | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |       919 | NS      | $30327.00     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Vor BioPharma Inc                              | Vor BioPharma Inc                                     | CUSIP: 929033207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       488 | NS      | $6344.00      | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Voyager Therapeutics Inc                       | Voyager Therapeutics Inc                              | CUSIP: 92915B106<br>LEI: 54930082S4XVR0ZWCC74 | Long             | EC               | CORP              | US        |      1560 | NS      | $6084.00      | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp                                    | Waters Corp                                           | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |       153 | NS      | $56720.16     | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Funds III                            | BlackRock Cash Funds: Institutional, SL Agency Shares | CUSIP: 066922519<br>LEI: 5493008LW2651I1QB503 | Long             | STIV             | RF                | US        |    403509 | NS      | $403710.69    | 4.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Wuxi Biologics Cayman Inc                      | Wuxi Biologics Cayman Inc                             | CUSIP: 000000000<br>LEI: 5493001TD2TH6VDTJU11 | Long             | EC               | CORP              | KY        |     20500 | NS      | $97013.16     | 0.98%             |  |  |  | No            |                  2 | On Loan: No      |
| BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES | BlackRock Cash Funds: Treasury, SL Agency Shares      | CUSIP: 066922477<br>LEI: 5493008LW2651I1QB503 | Long             | STIV             | RF                | US        |    220000 | NS      | $220000.00    | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Samsung Biologics Co Ltd                       | Samsung Biologics Co Ltd                              | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |        32 | NS      | $38672.28     | 0.39%             |  |  |  | No            |                  2 | On Loan: No      |
| Galderma Group AG                              | Galderma Group AG                                     | CUSIP: 000000000<br>LEI: 89450001OK6O8ELQ4584 | Long             | EC               | CORP              | CH        |       315 | NS      | $58715.67     | 0.59%             |  |  |  | No            |                  2 | On Loan: No      |
| Daiichi Sankyo Co Ltd                          | Daiichi Sankyo Co Ltd                                 | CUSIP: 000000000<br>LEI: 353800XGIU2IHQGC9504 | Long             | EC               | CORP              | JP        |      1000 | NS      | $18319.61     | 0.18%             |  |  |  | No            |                  2 | On Loan: No      |
| Zealand Pharma A/S                             | Zealand Pharma A/S                                    | CUSIP: 000000000<br>LEI: 549300ITBB1ULBL4CZ12 | Long             | EC               | CORP              | DK        |       498 | NS      | $33304.98     | 0.34%             |  |  |  | No            |                  2 | On Loan: No      |
| Nyxoah SA                                      | Nyxoah SA                                             | CUSIP: 000000000<br>LEI: 5493002O1ESKZ18OXR80 | Long             | EC               | CORP              | BE        |      1210 | NS      | $5747.50      | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Akeso Inc                                      | Akeso Inc                                             | CUSIP: 000000000<br>LEI: 254900ECWYGR3QW5GF30 | Long             | EC               | CORP              | KY        |      2000 | NS      | $28229.65     | 0.28%             |  |  |  | No            |                  2 | On Loan: No      |
| Alkermes PLC                                   | Alkermes PLC                                          | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |      1392 | NS      | $47174.88     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                                   | Biohaven Ltd                                          | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | VG        |       505 | NS      | $5974.15      | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Kiniksa Pharmaceuticals International Plc      | Kiniksa Pharmaceuticals International Plc             | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | GB        |       689 | NS      | $30260.88     | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                                  | Medtronic PLC                                         | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |      2818 | NS      | $290141.28    | 2.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Novocure Ltd                                   | Novocure Ltd                                          | CUSIP: 000000000<br>LEI: 213800YPP55UMHWA4826 | Long             | EC               | CORP              | JE        |      2144 | NS      | $26585.60     | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| QIAGEN NV                                      | QIAGEN NV                                             | CUSIP: 000000000<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |      2162 | NS      | $116034.54    | 1.17%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                                     | uniQure NV                                            | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |       437 | NS      | $9928.64      | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd                         | WaVe Life Sciences Ltd                                | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |       865 | NS      | $11193.10     | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-02-27

**Name of Applicant:** BlackRock ETF Trust

**Signature:** Chuck Pulsfort

**Name of Signer:** Chuck Pulsfort

**Title:** Assistant Treasurer